AT&T supports Pilot for Biotricity’s 
Biometric Remote Monitoring Solution

AT&T supports Pilot for Biotricity’s
Biometric Remote Monitoring Solutions

As reported today by IoT Tech News today and as the healthcare technology provider has announced, AT&T has become the preferred network partner for Biotricity’s biometric remote monitoring solutions, the healthcare technology provider has announced.

At present, AT&T is supporting a pilot of the solution. The development will see the telecommunications giant supporting Biotricity’s wearable medical devices with near real-time connectivity for data transmission. Connectivity will be initiated following the rollout of Biotricity’s flagship product, the Bioflux solution, which is expected to launch by the end of 2016.

Biotricity founder and CEO Waqaas Al-Siddiq said: “For medical device manufacturers to successfully enter and establish themselves in the new connected healthcare industry, it is imperative that they look beyond traditional forms of technological innovation. IoT, for example, would be an avenue for consideration and medical device manufacturers are uniquely positioned to be successful in this market, as they have a profound understanding of the regulatory process, critical applications, and patient risk.

“As we prepare to commercialise our first medical solution, we understand the importance of integrating IoT into next generation devices within the regulatory environment, as we believe there will be a true market advantage,” Al-Siddiq added.

IDC projects that the value of the worldwide IoT market will nearly triple to $1.7 trillion by 2020, revealing the importance of the impact of the industry the healthcare industry, and specifically medical devices which can provide relevant near real-time feedback to engage healthcare professionals in a timely manner. The integration of IoT and medical technology is set to be increasingly important as medical device manufacturers, healthcare practitioners, and enthusiasts continue to foster adoption of such break-through applications.

Breakthrough for Wearable Medical Devices
 Increasing the Efficiency and Effectiveness of Care
 S tockWatchIndex  and SWI Research (SWI) are not registered investment advisers and the information  provided herein or any other SWI publication is not to be construed as personal financial advice, or a solicitation to buy or sell stock. SWI makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in its publications or on its web sites. Some of the published information has been provided by the companies covered, generated by publicly available sources, or what SWI deems to be reliable third party entities, but SWI does not guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or  warrant any results from use of the information. Readers are encouraged to consult their personal financial adviser before making any decisions to buy, sell or hold any securities mentioned herein. StockWatchIndex is not responsible for any error, mistake or shortcoming that may be occasioned at the time of publishing of the information in this publication, any other SWI publication, or its web sites and is not obligated to update and/or correct information. No liability is accepted by StockWatchIndex whatsoever for any direct, indirect or consequential loss arising from the use of the information. SWI expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information provided. SWI has not been compensated for the publication of the information herein . The included information is subject to change without notice. Please visit!legal-ease/lmvw1   for a full text of our Disclaimer, Privacy policy and Terms of Use.